1. Home
  2. BFC vs ZYME Comparison

BFC vs ZYME Comparison

Compare BFC & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFC
  • ZYME
  • Stock Information
  • Founded
  • BFC 1894
  • ZYME 2003
  • Country
  • BFC United States
  • ZYME United States
  • Employees
  • BFC N/A
  • ZYME N/A
  • Industry
  • BFC Major Banks
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFC Finance
  • ZYME Health Care
  • Exchange
  • BFC Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • BFC 1.2B
  • ZYME 1.2B
  • IPO Year
  • BFC N/A
  • ZYME 2017
  • Fundamental
  • Price
  • BFC $125.28
  • ZYME $27.46
  • Analyst Decision
  • BFC Buy
  • ZYME Strong Buy
  • Analyst Count
  • BFC 2
  • ZYME 8
  • Target Price
  • BFC $142.00
  • ZYME $28.00
  • AVG Volume (30 Days)
  • BFC 60.2K
  • ZYME 1.9M
  • Earning Date
  • BFC 10-21-2025
  • ZYME 11-06-2025
  • Dividend Yield
  • BFC 1.44%
  • ZYME N/A
  • EPS Growth
  • BFC N/A
  • ZYME N/A
  • EPS
  • BFC 7.11
  • ZYME N/A
  • Revenue
  • BFC $168,778,000.00
  • ZYME $134,481,000.00
  • Revenue This Year
  • BFC $11.79
  • ZYME $65.21
  • Revenue Next Year
  • BFC $32.03
  • ZYME $20.39
  • P/E Ratio
  • BFC $17.64
  • ZYME N/A
  • Revenue Growth
  • BFC N/A
  • ZYME 116.21
  • 52 Week Low
  • BFC $92.49
  • ZYME $9.03
  • 52 Week High
  • BFC $135.72
  • ZYME $28.49
  • Technical
  • Relative Strength Index (RSI)
  • BFC 53.02
  • ZYME 78.25
  • Support Level
  • BFC $120.82
  • ZYME $21.89
  • Resistance Level
  • BFC $127.78
  • ZYME $26.19
  • Average True Range (ATR)
  • BFC 3.32
  • ZYME 1.52
  • MACD
  • BFC 0.39
  • ZYME 0.72
  • Stochastic Oscillator
  • BFC 75.86
  • ZYME 92.51

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: